The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices
- PMID: 33622088
- PMCID: PMC8832569
- DOI: 10.1177/1078155221995539
The safe handling of chemotherapy drugs in low- and middle-income countries: An overview of practices
Abstract
Introduction: The rising burden of cancer in low- and middle-income countries (LMICs) has led to substantial efforts to improve access to chemotherapy. The present study's objectives were to obtain an overview of the safe handling practices implemented in LMICs' healthcare facilities when dealing with chemotherapy drugs and to prioritize opportunities for improving them.
Methods: We conducted an online survey, from June 2018 to April 2019, among LMIC healthcare facilities dealing with chemotherapy drugs. Facilities were asked to self-assess their chemotherapy handling processes using Cyto-SAT, a self-assessment tool incorporating 134 items organized into 10 domains (management, personnel, logistics, prescription, preparation, administration, incident management, waste management, cleaning, and patient counselling). Data were recorded on an online platform (www.datapharma.ch/cyto-SAT).
Results: The survey enrolled 53 healthcare facilities (15 from low-income, 26 from lower-middle-income, and 12 from upper-middle-income countries). The median level of implementation of safe practices was 63% (Q1:39%-Q3:77%). Facilities in low-income countries (LICs) reported lower median levels of safe practices than middle-income countries (MICs) [LICs: 32% (Q1:24%-Q3:62%), Lower-MICs: 63% (Q1:49%-Q3:70%), Upper-MICs: 85% (Q1:77%-Q3:93%)]. The biggest differences between country categories were observed in the domains related to personnel, preparation processes, and incident management.
Conclusion: This overview of practices highlighted a large variability and major gaps in the safe handling of chemotherapy drugs in LMICs. Improvement strategies are needed to increase patient and staff safety and limit environmental contamination, especially in LICs. Safe handling programs should be part of continuing efforts to improve access to quality cancer drugs and should be integrated into national cancer control programs.
Keywords: Safe handling practices; chemotherapy; cytotoxic drugs; low- and middle-income countries; oncology.
Conflict of interest statement
Figures
Similar articles
-
Development and Evaluation of an e-Learning Module for Low- and Middle-Income Countries on the Safe Handling of Chemotherapy Drugs.J Cancer Educ. 2023 Feb;38(1):285-291. doi: 10.1007/s13187-021-02113-z. Epub 2021 Nov 17. J Cancer Educ. 2023. PMID: 34791602 Free PMC article.
-
Cyto-SAT: A self-assessment tool for the safe handling of cytotoxic drugs adapted for use in low- and middle-income countries.J Oncol Pharm Pract. 2021 Sep;27(6):1422-1431. doi: 10.1177/1078155220956687. Epub 2020 Sep 17. J Oncol Pharm Pract. 2021. PMID: 32941103
-
Development and Proof of Concept of an Audit Toolkit for the Safe Handling of Cytotoxic Drugs in Low- and Middle-Income Countries.JCO Glob Oncol. 2021 Sep;7:1480-1489. doi: 10.1200/GO.21.00205. JCO Glob Oncol. 2021. PMID: 34648387 Free PMC article.
-
Epidemiology, risk factors, and strategies to prevent and manage poisonings due to pharmaceuticals in children in low income and low-middle income countries: A systematic review.J Glob Health. 2023 Dec 29;13:04173. doi: 10.7189/jogh.13.04173. J Glob Health. 2023. PMID: 38154015 Free PMC article.
-
Culture media for clinical bacteriology in low- and middle-income countries: challenges, best practices for preparation and recommendations for improved access.Clin Microbiol Infect. 2021 Oct;27(10):1400-1408. doi: 10.1016/j.cmi.2021.05.016. Epub 2021 May 18. Clin Microbiol Infect. 2021. PMID: 34015533 Review.
Cited by
-
Oncology stewardship: Role of the pharmacists for contribution in low and middle-income countries.J Oncol Pharm Pract. 2023 Jun;29(4):956-957. doi: 10.1177/10781552231154465. Epub 2023 Feb 3. J Oncol Pharm Pract. 2023. PMID: 36734132 Free PMC article. No abstract available.
-
Cancer-Chemotherapy-Related Regimen Checks Performed by Pharmacists of General Hospitals Other than Cancer Treatment Collaborative Base Hospitals: A Multicenter, Prospective Survey.Pharmacy (Basel). 2023 Dec 20;12(1):1. doi: 10.3390/pharmacy12010001. Pharmacy (Basel). 2023. PMID: 38392922 Free PMC article.
-
Development and Evaluation of an e-Learning Module for Low- and Middle-Income Countries on the Safe Handling of Chemotherapy Drugs.J Cancer Educ. 2023 Feb;38(1):285-291. doi: 10.1007/s13187-021-02113-z. Epub 2021 Nov 17. J Cancer Educ. 2023. PMID: 34791602 Free PMC article.
-
A simple and inexpensive method to monitor and minimize exposure from manipulation of cytotoxic drugs.J Oncol Pharm Pract. 2024 Mar;30(2):257-262. doi: 10.1177/10781552231173878. Epub 2023 May 7. J Oncol Pharm Pract. 2024. PMID: 37151079 Free PMC article.
-
Assessing safe chemotherapy needs and practices in Ile-Ife, Nigeria: a multi-disciplinary quality improvement project.BMJ Open. 2024 Jun 4;14(6):e077154. doi: 10.1136/bmjopen-2023-077154. BMJ Open. 2024. PMID: 38834320 Free PMC article.
References
-
- Connor T, MacKenzie B, DeBord D, et al.. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings. National Institute for Occupational Safety and Health, Department of Health and Human Services, Centers for Disease Control and Prevention, www.cdc.gov/niosh/docs/2016-161/pdfs/2016-161.pdf (2016, accessed 8 February 2017).
-
- Connor TH, Burroughs G, McDiarmid M, et al.. NIOSH alert: preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings. Atlanta, GA: DHHS NIOSH, 2004, pp.1–50.
-
- Phillips J, Beam S, Brinker A, et al.. Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 2131–2131. - PubMed
-
- Greenall J, Shastay A, Vaida AJ, et al.. Establishing an international baseline for medication safety in oncology: findings from the 2012 ISMP international medication safety self assessment® for oncology. J Oncol Pharm Pract 2015; 21: 26–35. - PubMed
-
- ASHP Council on Professional Affairs. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health-Syst Pharm 2002; 59: 1648–1668. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous